Reperfusion Injury, Myocardial
9
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
11%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (9)
Effective Myocardial Protection Time of Del Nido Cardioplegia in Adult Cardiac Surgery
Effect of L-Carnitine on Biomarkers of Myocardial Reperfusion Injury in Patients With STEMI
Trans-coronary Cooling and Dilution for Cardioprotection During Revascularisation for ST-elevation Myocardial Infarction
Combined Antioxidant Therapy Against Myocardial Reperfusion Injury. Phase I Study.
The Role of Colchicine in Reducing The Rate of Myocardial Reperfusion Injury
Nitric Oxide-mediated Cardioprotection During Cardiac Surgery With Cardiopulmonary Bypass
Combination With Treg Levels and CMR to Assess the Severity and Prognosis of Reperfusion Injury After PPCI in STEMI Patients
Empagliflozin on Cardiac-renal Injury in Patients With STEAMI Patients After Primary PCI
Effects of Melatonin on Reperfusion Injury